Sign up to save your podcasts
Or
Share CME
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
CME
By ReachMDMedicine
CME episodes
- It All Starts With a PatientGuest: Jeff McIntyre
This series of bite-sized episodes will provide important information on MASLD and MASH in patients with type 2 diabetes. Drs. Naim Alkhouri and Robert Eckel and physician assistant Tessa Janovsky discuss best practices for screening, diagnosis, treatment, and management of MASH/MASLD.
4 min - MASLD in My Clinic: Hiding in Plain Sight?Guest: Robert H. Eckel, MD, FAHA, FACC, FNLA
This series of bite-sized episodes will provide important information on MASLD and MASH in patients with type 2 diabetes. Drs. Naim Alkhouri and Robert Eckel and physician assistant Tessa Janovsky discuss best practices for screening, diagnosis, treatment, and management of MASH/MASLD.
6 min - More Screening Recommendations? These Could Save Your Patient's LifeGuest: Tessa Janovsky, PA-C
This series of bite-sized episodes will provide important information on MASLD and MASH in patients with type 2 diabetes. Drs. Naim Alkhouri and Robert Eckel and physician assistant Tessa Janovsky discuss best practices for screening, diagnosis, treatment, and management of MASH/MASLD.
5 min - Treating Patients With T2D and MASLD: Is the Tide Changing?Guest: Naim Alkhouri, MD, FAASLD, DABOM
This series of bite-sized episodes will provide important information on MASLD and MASH in patients with type 2 diabetes. Drs. Naim Alkhouri and Robert Eckel and physician assistant Tessa Janovsky discuss best practices for screening, diagnosis, treatment, and management of MASH/MASLD.
6 min - My Patient's At 'Low Risk' for Clinically Significant Fibrosis: What Should I Do Now?Guest: Robert H. Eckel, MD, FAHA, FACC, FNLA
This series of bite-sized episodes will provide important information on MASLD and MASH in patients with type 2 diabetes. Drs. Naim Alkhouri and Robert Eckel and physician assistant Tessa Janovsky discuss best practices for screening, diagnosis, treatment, and management of MASH/MASLD.
6 min - Noninvasive Tests for Clinically Significant Fibrosis: That's The Hepatologist's Job, Right?Guest: Naim Alkhouri, MD, FAASLD, DABOM
This series of bite-sized episodes will provide important information on MASLD and MASH in patients with type 2 diabetes. Drs. Naim Alkhouri and Robert Eckel and physician assistant Tessa Janovsky discuss best practices for screening, diagnosis, treatment, and management of MASH/MASLD.
5 min - You Want Me to Perform a Liver Stiffness Test in My Clinic, Did I Hear That Right?Guest: Naim Alkhouri, MD, FAASLD, DABOM
This series of bite-sized episodes will provide important information on MASLD and MASH in patients with type 2 diabetes. Drs. Naim Alkhouri and Robert Eckel and physician assistant Tessa Janovsky discuss best practices for screening, diagnosis, treatment, and management of MASH/MASLD.
5 min - I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant FibrosisGuest: Naim Alkhouri, MD, FAASLD, DABOMGuest: Tessa Janovsky, PA-C
This series of bite-sized episodes will provide important information on MASLD and MASH in patients with type 2 diabetes. Drs. Naim Alkhouri and Robert Eckel and physician assistant Tessa Janovsky discuss best practices for screening, diagnosis, treatment, and management of MASH/MASLD.
6 min - M3: Managing the Cardiometabolic Risk in MASHGuest: Robert H. Eckel, MD, FAHA, FACC, FNLAGuest: Naim Alkhouri, MD, FAASLD, DABOM
This series of bite-sized episodes will provide important information on MASLD and MASH in patients with type 2 diabetes. Drs. Naim Alkhouri and Robert Eckel and physician assistant Tessa Janovsky discuss best practices for screening, diagnosis, treatment, and management of MASH/MASLD.
6 min - Practical Applications for Quality Improvement in Myelofibrosis Management: A Video Brief on Lessons LearnedHost: Joseph Kim, MD, MPH
This video brief will discuss quality improvement in myelofibrosis management. To highlight ways to improve care for patients with both primary and secondary myelofibrosis, we’ll examine the experiences of two cancer centers that engaged in quality improvement programs.
- Molecular Testing
- Symptom Assessment
- Prognostic Risk Assessment
- JAK Inhibitor Therapy
- Shared Decision-Making
- Interprofessional Team-Based Care Coordination
25 min